MADANAPHALA (RANDIA DUMETORUM LAM.): INTEGRATING CLASSICAL AYURVEDIC CONCEPTS WITH CONTEMPORARY PHARMACOLOGICAL EVIDENCE—A CRITICAL NARRATIVE REVIEW

Background: Madanaphala (Randia dumetorum Lam.) occupies a distinguished position in Ayurvedic therapeutics and is recognized as the principal Vamaka Dravya employed in Panchakarma, particularly in Vamana Karma. Traditionally, it has been used for the elimination of vitiated Kapha Dosha and the management of various Kapha-dominant disorders. Recent scientific investigations have expanded understanding of the plant beyond its classical emetic role, highlighting a broad spectrum of pharmacological activities and therapeutic applications. Objective: To critically evaluate contemporary evidence regarding the Ayurvedic significance, phytochemical constituents, pharmacological properties, standardization approaches, and therapeutic applications of Madanaphala, while examining its relevance in modern evidence-based healthcare. Methods: A targeted critical narrative review was conducted using peer-reviewed literature retrieved from electronic databases including PubMed, Scopus, and Google Scholar, along with relevant Ayurvedic texts and research publications. Emphasis was placed on contemporary studies investigating standardization, pharmacological activities, phytochemical characterization, and comparative therapeutic applications of Madanaphala. Results: Available evidence indicates that Madanaphala contains a diverse array of bioactive constituents, including saponins, glycosides, d-mannitol, scopoletin, randiosides, coumarins, and triterpenoid compounds. Standardization studies have established objective dosage parameters for Antar-nakhamusti Pramana, thereby enhancing consistency and reproducibility in Vamana Karma. Experimental investigations have reported analgesic, anti-inflammatory, antimicrobial, antifungal, antioxidant, hepatoprotective, and immunomodulatory activities. Furthermore, comparative Ayurvedic analyses suggest that Jeemutaka may serve as a potential alternative Vamaka Dravya in selected clinical conditions such as Urdhwaga Amlapitta. Conclusion: Madanaphala remains one of the most important medicinal plants described in Ayurveda and continues to hold significant relevance in Panchakarma practice. Contemporary pharmacological and phytochemical evidence supports several of its traditional therapeutic applications. However, well-designed clinical trials, toxicological evaluations, and further standardization studies are required to facilitate its safe and evidence-based integration into modern healthcare systems.